About
Mitochondrial Disease Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (22)
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
264
By Phase
PHASE3: 1PHASE2: 4PHASE1: 1
By Status
COMPLETED: 4NOT_YET_RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06451757Lead Sponsor
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
PHASE3Not yet recruiting
150 participants
Started: Nov 28, 2025 · Completed: Jan 2, 2028
NCT04604548Lead Sponsor
The KHENEREXT Study
PHASE2Completed
11 participants
Started: Aug 9, 2021 · Completed: Jun 1, 2023
NCT04846036Lead Sponsor
The KHENERGYC Study
PHASE2Suspended
24 participants
Started: Feb 1, 2021 · Completed: Dec 1, 2025
NCT04165239Lead Sponsor
The KHENERGYZE Study
PHASE2Completed
27 participants
Started: Oct 30, 2019 · Completed: May 24, 2022
NCT02909400Lead Sponsor
The KHENERGY Study
PHASE2Completed
20 participants
Started: Sep 30, 2016 · Completed: Jul 31, 2017
Locations (1)
Headquarters
Nijmegen, Netherlands
Map
Loading map...